OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of Interleukin 17 on the cardiovascular system
Marie Robert, Pierre Miossec
Autoimmunity Reviews (2017) Vol. 16, Iss. 9, pp. 984-991
Closed Access | Times Cited: 130

Showing 26-50 of 130 citing articles:

Multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS
Richa Batra, William Whalen, Sergio Alvarez-Mulett, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 9, pp. e1010819-e1010819
Open Access | Times Cited: 25

The Th17 Pathway in Vascular Inflammation: Culprit or Consort?
Marie Robert, Pierre Miossec, A. Hot
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24

A Role of IL-17 in Rheumatoid Arthritis Patients Complicated With Atherosclerosis
Jiexin Wang, Linxi He, Weihong Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23

IL‐17 in neonatal health and disease
Shelley M. Lawrence, J. Lauren Ruoss, James L. Wynn
American Journal of Reproductive Immunology (2017) Vol. 79, Iss. 5
Open Access | Times Cited: 45

The pleiotropic role of interleukin-17 in atherosclerosis
Gamal Allam, Adel Abdel‐Moneim, Asmaa M. Gaber
Biomedicine & Pharmacotherapy (2018) Vol. 106, pp. 1412-1418
Closed Access | Times Cited: 45

Additive or Synergistic Interactions Between IL-17A or IL-17F and TNF or IL-1β Depend on the Cell Type
Mélissa Noack, Audrey Beringer, Pierre Miossec
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 41

Interleukin-17 and lupus: enough to be a target? For which patients?
Marie Robert, Pierre Miossec
Lupus (2019) Vol. 29, Iss. 1, pp. 6-14
Open Access | Times Cited: 40

Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?
Carolina Lavoz, Sandra Rayego‐Mateos, Macarena Orejudo, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 1, pp. 272-272
Open Access | Times Cited: 36

PCOS without hyperandrogenism is associated with higher plasma Trimethylamine N-oxide levels
Jiayu Huang, Lin Liu, Chunyan Chen, et al.
BMC Endocrine Disorders (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 36

The Risk of Cardiovascular Diseases in Axial Spondyloarthritis. Current Insights
Éric Toussirot
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 29

Immune and Non-Immune Inflammatory Cells Involved in Autoimmune Fibrosis: New Discoveries
Margherita Sisto, Sabrina Lisi
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3801-3801
Open Access | Times Cited: 12

MMP-2 and its implications on cardiac function and structure: Interplay with inflammation in hypertension
Thaís Ribeiro Vitorino, Alejandro Ferraz do Prado, Stêfany B. A. Cau, et al.
Biochemical Pharmacology (2023) Vol. 215, pp. 115684-115684
Closed Access | Times Cited: 12

Interleukins in Platelet Biology: Unraveling the Complex Regulatory Network
Miao Huang, Long Wang, Qianhui Zhang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 109-109
Open Access | Times Cited: 4

Subclinical Atherosclerosis in Primary Sjögren's Syndrome: Does Inflammation Matter?
Elena Bartoloni, Alessia Alunno, Giacomo Cafaro, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 31

Biological Aspects of Inflamm-Aging in Childhood Cancer Survivors
Francesca Rossi, Alessandra Di Paola, Elvira Pota, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4933-4933
Open Access | Times Cited: 27

Inflammation and Immunity: From an Adipocyte's Perspective
Calvin C. Chan, Michelle S. M. A. Damen, Pablo C. Alarcon, et al.
Journal of Interferon & Cytokine Research (2019) Vol. 39, Iss. 8, pp. 459-471
Open Access | Times Cited: 26

Apremilast effectively inhibits TNFα‐induced vascular inflammation in human endothelial cells
Matthias S. Otto, Britta Dorn, T. Grasmik, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 36, Iss. 2, pp. 237-246
Open Access | Times Cited: 23

IL (Interleukin)-17A Acts in the Brain to Drive Neuroinflammation, Sympathetic Activation, and Hypertension
Yiling Cao, Yang Yu, Baojian Xue, et al.
Hypertension (2021) Vol. 78, Iss. 5, pp. 1450-1462
Open Access | Times Cited: 22

Emerging Anti-Inflammatory COPD Treatments: Potential Cardiovascular Impacts
Mario Cazzola, Luigino Calzetta, Paola Rogliani, et al.
International Journal of COPD (2024) Vol. Volume 19, pp. 2481-2495
Open Access | Times Cited: 3

Aryl Hydrocarbon Receptor Agonist VAF347 Impedes Retinal Pathogenesis in Diabetic Mice
Thomas E. Zapadka, Sarah I. Lindstrom, Julia C. Batoki, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4335-4335
Open Access | Times Cited: 20

Contribution of Interleukin-17A to Retinal Degenerative Diseases
Huimin Zhong, Xiaodong Sun
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14

Scroll to top